Loading clinical trials...
Loading clinical trials...
Autosomal Dominant Polycystic Kidney Disease Patient Registry
The purpose of the ADPKD Registry is to create an online patient network that includes at least 5,000 people with Autosomal Dominant Polycystic Kidney Disease (ADPKD) who contribute data on their health and other topics. The ADPKD Patient Registry aims to support important scientific discoveries and support patient needs in the following ways: * Connect ADPKD patients with opportunities to join clinical studies. * Collect data for the research community to better describe the ADPKD disease experience and improve patient care. * Engage with patients by measuring quality of life outcomes.
The ADPKD Registry will be a patient-powered network of people with ADPKD. This data will inform new research to improve ADPKD patient outcomes, learn more about the patient journey and discover unmet medical needs. We collect data most relevant to your ADPKD diagnosis, its major symptoms and management, as well as key demographic data (no personally identifiable information is shared). A Registry keeps information in one place making it easier for researchers to utilize Registry information while still protecting the privacy of those who take part. The Registry will be hosted on a secure, online platform that patients can access using their home computers, tablets or phones. The purpose of the ADPKD Registry is to allow PKD patients to: * Connect with researchers and express interest in taking part in certain clinical studies for ADPKD, including studies of new medications and other treatments. * Take confidential health-related surveys. These surveys are aimed at better understanding of the health of people with PKD across their lifespans.
Age
All ages
Sex
ALL
Healthy Volunteers
No
PKD Foundation
Kansas City, Missouri, United States
Start Date
September 4, 2019
Primary Completion Date
September 4, 2029
Completion Date
September 4, 2029
Last Updated
November 18, 2023
3,000
ESTIMATED participants
Lead Sponsor
PKD Foundation
NCT06867471
NCT06036992
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05215964